119 related articles for article (PubMed ID: 38040684)
1. Author Correction: Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands.
Linossi EM; Li K; Veggiani G; Tan C; Dehkhoda F; Hockings C; Calleja DJ; Keating N; Feltham R; Brooks AJ; Li SS; Sidhu SS; Babon JJ; Kershaw NJ; Nicholson SE
Nat Commun; 2023 Dec; 14(1):7951. PubMed ID: 38040684
[No Abstract] [Full Text] [Related]
2. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
[TBL] [Abstract][Full Text] [Related]
3. SOCS2 regulation of growth hormone signaling requires a canonical interaction with phosphotyrosine.
Li K; Meza Guzman LG; Whitehead L; Leong E; Kueh A; Alexander WS; Kershaw NJ; Babon JJ; Doggett K; Nicholson SE
Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36398696
[TBL] [Abstract][Full Text] [Related]
4. Prediction of solvation sites at the interface of Src SH2 domain complexes using molecular dynamics simulations.
Geroult S; Hooda M; Virdee S; Waksman G
Chem Biol Drug Des; 2007 Aug; 70(2):87-99. PubMed ID: 17683370
[TBL] [Abstract][Full Text] [Related]
5. High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system.
Mandine E; Jean-Baptiste V; Vayssière B; Gofflo D; Bénard D; Sarubbi E; Deprez P; Baron R; Superti-Furga G; Lesuisse D
Biochem Biophys Res Commun; 2002 Oct; 298(2):185-92. PubMed ID: 12387813
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.
Ivancic M; Daly RJ; Lyons BA
J Biomol NMR; 2003 Nov; 27(3):205-19. PubMed ID: 12975581
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of tensin2 SH2 domain and its phosphotyrosine-independent interaction with DLC-1.
Dai K; Liao S; Zhang J; Zhang X; Tu X
PLoS One; 2011; 6(7):e21965. PubMed ID: 21765928
[TBL] [Abstract][Full Text] [Related]
9. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
[TBL] [Abstract][Full Text] [Related]
10. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Rui L; Gunter DR; Herrington J; Carter-Su C
Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
[TBL] [Abstract][Full Text] [Related]
11. An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways.
Wang Z; Zhou H; Yue X; Zhu J; Yang Y; Liu M
Anal Bioanal Chem; 2022 Jan; 414(1):497-506. PubMed ID: 34021368
[TBL] [Abstract][Full Text] [Related]
12. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
[TBL] [Abstract][Full Text] [Related]
13. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
Mayer BJ; Hirai H; Sakai R
Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
15. The beta D-sheet residues of the Lck-derived SH2 domain determine specificity of the interaction with tyrosine-phosphorylated ligands in Ramos B cells.
von Bonin A; Wienands J; Manning U; Zuber JF; Baumann G
J Biol Chem; 1994 Dec; 269(52):33035-41. PubMed ID: 7528744
[TBL] [Abstract][Full Text] [Related]
16. HCV NS5A protein containing potential ligands for both Src homology 2 and 3 domains enhances autophosphorylation of Src family kinase Fyn in B cells.
Nakashima K; Takeuchi K; Chihara K; Horiguchi T; Sun X; Deng L; Shoji I; Hotta H; Sada K
PLoS One; 2012; 7(10):e46634. PubMed ID: 23077515
[TBL] [Abstract][Full Text] [Related]
17. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
18. An intramolecular energetic network regulates ligand recognition in a SH2 domain.
Nardella C; Pagano L; Pennacchietti V; Felice MD; Matteo SD; Diop A; Malagrinò F; Marcocci L; Pietrangeli P; Gianni S; Toto A
Protein Sci; 2023 Aug; 32(8):e4729. PubMed ID: 37468946
[TBL] [Abstract][Full Text] [Related]
19. A Point Mutation in Suppressor of Cytokine Signalling 2 (Socs2) Increases the Susceptibility to Inflammation of the Mammary Gland while Associated with Higher Body Weight and Size and Higher Milk Production in a Sheep Model.
Rupp R; Senin P; Sarry J; Allain C; Tasca C; Ligat L; Portes D; Woloszyn F; Bouchez O; Tabouret G; Lebastard M; Caubet C; Foucras G; Tosser-Klopp G
PLoS Genet; 2015 Dec; 11(12):e1005629. PubMed ID: 26658352
[TBL] [Abstract][Full Text] [Related]
20. Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain.
Hua Y; Yuan X; Shen YH; Wang J; Azeem W; Yang S; Gade A; Lellahi SM; Øyan AM; Ke X; Zhang WD; Kalland KH
Front Pharmacol; 2022; 13():836724. PubMed ID: 35712699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
